MarketScreener Editorial Features Intellego Technologies AB
Equities
INT
SE0016075063
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39.50 SEK | +1.41% |
|
+2.33% | -3.66% |
Jan. 14 | Sweden's Intellego Technologies Signs Sales, Marketing Rights Deal in US | MT |
Jan. 14 | Intellego CEO Claes Lindahl increases his shareholding | FW |
- Stock Market
- Equities
- INT Stock
- News Intellego Technologies AB
- MarketScreener Editorial Features